377 related articles for article (PubMed ID: 33781887)
1. Curcumin encapsulation in nanostructures for cancer therapy: A 10-year overview.
D'Angelo NA; Noronha MA; Kurnik IS; Câmara MCC; Vieira JM; Abrunhosa L; Martins JT; Alves TFR; Tundisi LL; Ataide JA; Costa JSR; Jozala AF; Nascimento LO; Mazzola PG; Chaud MV; Vicente AA; Lopes AM
Int J Pharm; 2021 Jul; 604():120534. PubMed ID: 33781887
[TBL] [Abstract][Full Text] [Related]
2. Advances in nanotechnology-based delivery systems for curcumin.
Sun M; Su X; Ding B; He X; Liu X; Yu A; Lou H; Zhai G
Nanomedicine (Lond); 2012 Jul; 7(7):1085-100. PubMed ID: 22846093
[TBL] [Abstract][Full Text] [Related]
3. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
[TBL] [Abstract][Full Text] [Related]
4. Curcumin Based Drug Delivery Systems for Cancer Therapy.
Tiwari A; Jain SK
Curr Pharm Des; 2020; 26(42):5430-5440. PubMed ID: 32348207
[TBL] [Abstract][Full Text] [Related]
5. Recent progress in studying curcumin and its nano-preparations for cancer therapy.
Liu J; Chen S; Lv L; Song L; Guo S; Huang S
Curr Pharm Des; 2013; 19(11):1974-93. PubMed ID: 23116308
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in colloidal delivery systems for nutraceuticals: A case study - Delivery by Design of curcumin.
Kharat M; McClements DJ
J Colloid Interface Sci; 2019 Dec; 557():506-518. PubMed ID: 31542691
[TBL] [Abstract][Full Text] [Related]
7. An updated and comprehensive review on the potential health effects of curcumin-encapsulated micro/nanoparticles.
Rashwan AK; Karim N; Xu Y; Hanafy NAN; Li B; Mehanni AE; Taha EM; Chen W
Crit Rev Food Sci Nutr; 2023; 63(29):9731-9751. PubMed ID: 35522080
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and anti-cancer activity of Pluronic F68-curcumin conjugate micelles.
Cai Y; Sun Z; Fang X; Fang X; Xiao F; Wang Y; Chen M
Drug Deliv; 2016 Sep; 23(7):2587-2595. PubMed ID: 26066393
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application.
Ma Z; Wang N; He H; Tang X
J Control Release; 2019 Dec; 316():359-380. PubMed ID: 31682912
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin nanoformulations on therapy against cancer: An overview from the last 10 years.
D'Angelo NA; Noronha MA; Câmara MCC; Kurnik IS; Feng C; Araujo VHS; Santos JHPM; Feitosa V; Molino JVD; Rangel-Yagui CO; Chorilli M; Ho EA; Lopes AM
Biomater Adv; 2022 Feb; 133():112623. PubMed ID: 35525766
[TBL] [Abstract][Full Text] [Related]
11. Drug induced micellization into ultra-high capacity and stable curcumin nanoformulations: Physico-chemical characterization and evaluation in 2D and 3D in vitro models.
Lübtow MM; Nelke LC; Seifert J; Kühnemundt J; Sahay G; Dandekar G; Nietzer SL; Luxenhofer R
J Control Release; 2019 Jun; 303():162-180. PubMed ID: 30981815
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic, Genotoxic and Senolytic Potential of Native and Micellar Curcumin.
Beltzig L; Frumkina A; Schwarzenbach C; Kaina B
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371895
[TBL] [Abstract][Full Text] [Related]
13. Liposomal curcumin and its application in cancer.
Feng T; Wei Y; Lee RJ; Zhao L
Int J Nanomedicine; 2017; 12():6027-6044. PubMed ID: 28860764
[TBL] [Abstract][Full Text] [Related]
14. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells.
Patil S; Choudhary B; Rathore A; Roy K; Mahadik K
Phytomedicine; 2015 Nov; 22(12):1103-11. PubMed ID: 26547533
[TBL] [Abstract][Full Text] [Related]
15. Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers.
Kabir MT; Rahman MH; Akter R; Behl T; Kaushik D; Mittal V; Pandey P; Akhtar MF; Saleem A; Albadrani GM; Kamel M; Khalifa SAM; El-Seedi HR; Abdel-Daim MM
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33800000
[TBL] [Abstract][Full Text] [Related]
16. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin.
Mohanty C; Das M; Sahoo SK
Expert Opin Drug Deliv; 2012 Nov; 9(11):1347-64. PubMed ID: 22971222
[TBL] [Abstract][Full Text] [Related]
17. The bioavailability, metabolism and microbial modulation of curcumin-loaded nanodelivery systems.
Chang R; Chen L; Qamar M; Wen Y; Li L; Zhang J; Li X; Assadpour E; Esatbeyoglu T; Kharazmi MS; Li Y; Jafari SM
Adv Colloid Interface Sci; 2023 Aug; 318():102933. PubMed ID: 37301064
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial Activity of Curcumin in Nanoformulations: A Comprehensive Review.
Trigo-Gutierrez JK; Vega-Chacón Y; Soares AB; Mima EGO
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281181
[TBL] [Abstract][Full Text] [Related]
19. Curcumin-loaded self-nanomicellizing solid dispersion system: part I: development, optimization, characterization, and oral bioavailability.
Parikh A; Kathawala K; Song Y; Zhou XF; Garg S
Drug Deliv Transl Res; 2018 Oct; 8(5):1389-1405. PubMed ID: 29845380
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of Biological and Pharmacological Properties of an Encapsulated Polyphenol: Curcumin.
Witika BA; Makoni PA; Matafwali SK; Mweetwa LL; Shandele GC; Walker RB
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
